26 research outputs found
Evaluation of left atrial systolic function in noncompaction cardiomyopathy by real-time three-dimensional echocardiography
Background Noncompaction cardiomyopathy (NCCM) is a rare disorder with persistance of the embryonic pattern of myoarchitecture. NCCM is characterized by loosened, spongy myocardium associated with a high incidence of systolic and diastolic left ventricular (LV) dysfunction and heart failure (HF). It is known that LV dysfunction contributes to elevated left atrial (LA) and pulmonary vascular pressures, however atrial function has not been examined in NCCM. The objective of the present study was to assess LA systolic function characterized by LA ejection force (LAEF) in NCCM patients using real-time three-dimensional echocardiography (RT3DE) and to compare to control subjects. Methods The study comprised 17 patients with an established diagnosis of NCCM and their results were compared to 17 healthy age-matched controls with no evidence of cardiovascular disease. Forty-one percent of NCCM patients were in NYHA functional class II / III HF. Previously proposed echocardiographic diagnostic criteria for NCCM were used. All patients underwent conventional two-dimensional echocardiography and RT3DE. LAEF was measured based on MA annulus diameter (LAEF3D-MAD) and area (LAEF3D-MAA) using RT3DE. Results The presence and severity of mitral regurgitation were more frequent in NCCM patients than in control subjects. LV diameters and mitral annulus were significantly increased in NCCM patients. Compared with control subjects, both LAEF3D-MAD (3.8 ± 2.2 vs 2.3 ± 1.0 kdyne, P < 0.05) and LAEF3D-MAA (12.7 ± 7.6 vs 4.9 ± 2.1 kdyne, P < 0.01) were significantly increased in NCCM patients. Conclusions LAEF as a characteristic of LA systolic function is increased in NCCM patients compared to normal individuals. These results can suggest compensating left atrial work against the dysfunctional LV in NCCM patients
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
Current tools for cardiovascular disease (CVD) risk assessment in asymptomatic individuals are imperfect. Preventive measures aimed only at individuals deemed high risk by current algorithms neglect large numbers of low-risk and intermediate-risk individuals who are destined to develop CVD and who would benefit from early and aggressive treatment. Natriuretic peptides have the potential both to identify individuals at risk for future cardiovascular events and to help detect subclinical CVD. Choosing the appropriate subpopulation to target for natriuretic peptide testing will help maximize the performance and the cost effectiveness. The combined use of multiple risk markers, including biomarkers, genetic testing, and imaging or other noninvasive measures of risk, offers promise for further refining risk assessment algorithms. Recent studies have highlighted the utility of natriuretic peptides for preoperative risk stratification; however, cost effectiveness and outcomes studies are needed to affirm this and other uses of natriuretic peptides for cardiovascular risk assessment in asymptomatic individuals
Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age
<p>Abstract</p> <p>Background</p> <p>In <it>Plasmodium falciparum</it>-infected children, the relationships between blood cell histopathology, blood plasma components, development of immunocompetence and disease severity remain poorly understood. Blood from Nigerian children with uncomplicated malaria was analysed to gain insight into these relationships. This investigation presents evidence for circulating neutrophil extracellular traps (NETs) and antinuclear IgG antibodies (ANA). The presence of NETs and ANA to double-stranded DNA along with the cytokine profiles found suggests autoimmune mechanisms that could produce pathogenesis in children, but immunoprotection in adults.</p> <p>Methods</p> <p>Peripheral blood smear slides and blood samples obtained from 21 Nigerian children under six years of age, presenting with uncomplicated malaria before and seven days after initiation of sulphadoxine-pyrimethamine (SP) treatment were analysed. The slides were stained with Giemsa and with DAPI. Levels of the pro-inflammatory cytokines IFN-γ, IL-2, TNF, CRP, and IL-6, select anti-inflammatory cytokines TGF-β and IL-10, and ANA were determined by immunoassay.</p> <p>Results</p> <p>The children exhibited circulating NETs with adherent parasites and erythrocytes, elevated ANA levels, a Th2 dominated cytokine profile, and left-shifted leukocyte differential counts. Nonspecific ANA levels were significant in 86% of the children pretreatment and in 100% of the children seven days after SP treatment, but in only 33% of age-matched control samples collected during the season of low parasite transmission. Levels of ANA specific for dsDNA were significant in 81% of the children both pre-treatment and post treatment.</p> <p>Conclusion</p> <p>The results of this investigation suggest that NET formation and ANA to dsDNA may induce pathology in falciparum-infected children, but activate a protective mechanism against falciparum malaria in adults. The significance of in vivo circulating chromatin in NETs and dsDNA ANA as a causative factor in the hyporesponsiveness of CpG oligonucleotide-based malaria vaccines is discussed.</p
The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst
After the introduction of statins in the market as effective lipid lowering agents, they were shown to have effects other than lipid lowering. These actions were collectively referred to as 'pleiotropic actions of statins.' Pleiotropism of statins formed the basis for evaluating statins for several indications other than lipid lowering. Evidence both in favour and against is available for several of these indications. The current review attempts to critically summarise the available data for each of these indications
Left atrial mechanical adaptation to long-standing hemodynamic loads based on pressure-volume relations
Left atrial (LA) adaptation during the development of left ventricular
(LV) dysfunction is not fully understood. We performed echocardiographic
assessment of LA volumes simultaneously with recordings of pulmonary
wedge pressures in 60 patients. Twenty patients had no structural or
functional LV abnormalities, 20 had a recent myocardial infarction with
LV dysfunction, and 20 suffered from congestive heart failure (CHF).
Pressure-volume loops were obtained at baseline and during increases in
in LA pressure produced by normal saline infusion. LA afterload was
estimated by the effective LV elastance (E-LV). Atrioventricular
coupling was calculated by the E-LV/E-es ratio (where E-es is the
end-systolic elastance). E-es increased in patients with myocardial
infarction (0.80 +/- 0.09 mm Hg/ml, p <0.001); whereas it decreased in
patients with CHF (0.22 +/- 0.05 mm Hg/ml, p <0.001) compared with
controls (0.61 +/- 0.07 mm Hg/ml). Similarly, stroke workload increased
in patients with myocardial infarction (60.7 +/- 7.3 mm Hg.ml, p
<0.001), whereas it decreased in patients with CHF (25.4 +/- 2.2 mm
Hg.ml, p <0.001) compared with controls (44.8 +/- 5.5 mm Hg.ml). In all
patients LA stiffness (slope of the relation of the filling portion of
the pressure-volume loop) was increased compared with controls
(controls: 0.13 +/- 0.04, patients with myocardial infarction: 0.22 +/-
0.05, and patients with CHF: 0.27 +/- 0.05 mm Hg/ml, p <0.001 for both
comparisons). Moreover, the E-LV/E-es ratio increased gradually as LV
function deteriorated (controls: 1.06 +/- 0.10, patients with myocardial
infarction: 1.35 +/- 0.16, and patients with CHF: 6.90 +/- 0.84, p
<0.001). Thus, early in heart failure, LA pump function is augmented but
LA stiffness increases and work mismatch occurs. With further
progression of LV dysfunction, LA pump function decreases as a result of
increased afterload imposed on the LA myocardium. (C) 1998 by Excerpta
Medica, Inc
Acute changes of left atrial distensibility in congestive heart failure
Background: Investigations of the left atrial (LA) distensibility have
revealed that it plays a major role in atrial function; however, LA
distensibility has not as yet been studied in congestive heart failure
(CHF).
Hypothesis: The study was undertaken to determine the effects of acute
administration of esmolol, isosorbide dinitrate, dobutamine, and normal
saline infusion on LA dimension, pressure, and distensibility.
Methods: The study included 23 patients with CHF (18 with ischemic heart
disease and 5 with idiopathic dilated cardiomypathy). Left atrial
diameters (D) and pressures (P) were recorded at rest and thereafter
during acute tests. P and D data during the ascending limb of the V loop
were fitted to the exponential function P = b.e(ad), where a is the
passive elastic chamber stiffness constant and b is the elastic
constant. The instantaneous diastolic LA distensibility (IDLAD) was
calculated as 1/(dP/dD)= 1/a.P.
Results: The constant, a, increased significantly after normal saline
and esmolol infusion (p<0.001), while it significantly decreased after
isosorbide dinitrate (p<0.001) and dobutamine administration (p<0.05)
compared with base line. Instantaneous diastolic LA distensibility (in
mm/Hg) was 0.16 at baseline; it significantly increased after isosorbide
dinitrate (0.32) and dobutamine (0.24) administration, while it
significantly decreased after normal saline (0.11) and esmolol (0.12)
infusion (p<0.001 for all).
Conclusion: In CHF, LA distensibility may acutely increase with
vasodilators or inotropics or may decrease with beta blockade or volume
loading
Simulation of Left Atrial Function Using a Multi-Scale Model of the Cardiovascular System
During a full cardiac cycle, the left atrium successively behaves as a reservoir, a conduit and a pump. This complex behavior makes it unrealistic to apply the time-varying elastance theory to characterize the left atrium, first, because this theory has known limitations, and second, because it is still uncertain whether the load independence hypothesis holds. In this study, we aim to bypass this uncertainty by relying on another kind of mathematical model of the cardiac chambers. In the present work, we describe both the left atrium and the left ventricle with a multi-scale model. The multi-scale property of this model comes from the fact that pressure inside a cardiac chamber is derived from a model of the sarcomere behavior. Macroscopic model parameters are identified from reference dog hemodynamic data. The multi-scale model of the cardiovascular system including the left atrium is then simulated to show that the physiological roles of the left atrium are correctly reproduced. This include a biphasic pressure wave and an eight-shaped pressure-volume loop. We also test the validity of our model in non basal conditions by reproducing a preload reduction experiment by inferior vena cava occlusion with the model. We compute the variation of eight indices before and after this experiment and obtain the same variation as experimentally observed for seven out of the eight indices. In summary, the multi-scale mathematical model presented in this work is able to correctly account for the three roles of the left atrium and also exhibits a realistic left atrial pressure-volume loop. Furthermore, the model has been previously presented and validated for the left ventricle. This makes it a proper alternative to the time-varying elastance theory if the focus is set on precisely representing the left atrial and left ventricular behaviors